SNIBE(SZ:300832) Xin Lang Cai Jing·2025-09-11 03:24Core Viewpoint - The company, Shenzhen New Industry Biomedical Engineering Co., Ltd., has shown a mixed performance in stock price and financial results, with a recent increase in stock price but a decline in revenue and net profit year-on-year [1][2]. Financial Performance - As of June 30, 2025, the company reported a revenue of 2.185 billion yuan, a year-on-year decrease of 1.18% [2]. - The net profit attributable to shareholders was 771 million yuan, reflecting a year-on-year decrease of 14.62% [2]. - The company has distributed a total of 3.860 billion yuan in dividends since its A-share listing, with 2.357 billion yuan distributed in the last three years [3]. Stock Market Activity - On September 11, the stock price increased by 2.05%, reaching 69.19 yuan per share, with a trading volume of 120 million yuan and a turnover rate of 0.26% [1]. - The total market capitalization of the company is 54.364 billion yuan [1]. - Year-to-date, the stock price has decreased by 0.52%, but it has increased by 6.73% over the last five trading days and by 20.75% over the last 20 days [1]. Shareholder Information - As of June 30, 2025, the number of shareholders decreased by 19.09% to 15,600, while the average number of tradable shares per person increased by 23.59% to 43,743 shares [2]. - The top ten circulating shareholders include significant institutional investors, with Hong Kong Central Clearing Limited being the fifth largest shareholder, increasing its holdings by 11.0924 million shares [3].